Slide 1: Transforming Tomorrow Together
Transforming Tomorrow Together Renishaw plc Interim results 13 February 2025 Steady progress in mixed market conditions with demand picking up in H2
Slide 2: Sir David Roberts McMurtry (1940 to 2024)
Sir David Roberts McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE (1940 to 2024) Slide 2
Slide 3: Revenue
Revenue Half-year revenue £m 400 Mixed conditions, with growth for position encoders, 350 offset by weaker metrology demand 300 67.0 69.1 79.2 83.6 77.9 72.1 92.3 77.7 250 Revenue 3% higher at £341.4m 63.6 51.7 54.7 95.5 110.3 102.4 114.1 97.2 110.8 102.3 200 94.6 • 2% growth at constant currency, e
Slide 4: Profitability
Profitability Key H1 metrics – FY2025 vs FY20242 Continuing control of fixed costs and focus on efficiency, 2025 2024 Change £m £m % whilst maintaining our commitment to long-term growth Revenue 341.4 330.5 3 Profit before tax1 2% higher at £57.5m Operating profit 51.6 47.2 9 • Gross margin (ex. eng
Slide 5: Financial highlights
Financial highlights 2025 2024 Change Revenue £m 800 £m £m % 671.1 688.6 691.3 700 565.6 600 Revenue 341.4 330.5 3 510.2 500 345.9 340.9 360.8 Operating profit 51.6 47.2 9 310.5 400 250.8 Profit before tax 57.5 56.5 2 300 200 325.2 347.7 330.5 341.4 259.4 255.1 100 Tax (11.6) (11.4) 2 0 2020 2021 20
Slide 6: Income statement
Income statement 2025 2024 Adjusted profit before tax bridge £m £m % £m % Change % 70.0 Revenue 341.4 100 330.5 100 - 9.9 0.6 60.0 -5.1 -1.0 57.5 56.5 -2.8 -0.7 Cost of sales (131.5) (39) (130.5) (39) 1 50.0 Engineering (incl. R&D) (50.5) (14) (45.4) (13) 11 40.0 Gross profit 159.4 47 154.6 47 3 30.
Slide 7: Sources and uses of cash
Sources and uses of cash 400 350 3.4 8.4 6.1 99.9 300 -37.9 -23.4 250 £m 1.8 0.3 233.2 217.8 -43.2 200 150 100 50 0 1 Operating profit, before non-cash items and R&D costs 2 Working capital 3 Interested received 4 Amounts received from joint venture 5 Research and development (R&D) costs 6 Capital e
Slide 8: Investment in our future
New manufacturing halls at Miskin, South Wales Investment in our future Capital expenditure • £23.4m capex in H1 FY2025, including manufacturing equipment and factory automation to support growth • Planned capex spend for full-year is c. £40m • Completed transfer of AGILITY® CMM and AM machine produ
Slide 9: Our purpose
Our purpose Transforming Tomorrow Together We make it possible to create the products, materials and therapies that will define our world in the decades to come and touch billions of lives Analytical instruments Manufacturing technologies & medical devices END-USE Semicon production Machine Robotics
Slide 10: Long-term value creation model
Long-term value creation model Targeting high single digit through-cycle organic growth and >20% operating profit margin Well positioned in markets growing at >5% 1 p.a. Strategy driving consistent outperformance Manufacturing machine Industrial Growing in Increasing Extending into performance autom
Slide 11: Growing in existing markets
Growing in existing markets Growing in existing markets Aim to increase revenue by driving up probe fitment levels, offering higher value sensors and by winning more customers who build machinery H1 FY2025 progress Introduced enhancements to our Launched enhancements to our Continued to grow revenue
Slide 12: Increasing the value of the technology we sell
Increasing the value of the technology we sell Increasing technology value Aim to provide our end-user customers with complete solutions to capture a greater proportion of their investment H1 FY2025 progress Launched the RenAM 500D dual laser AM machine, To increase the adoption of AM for a wider ra
Slide 13: Extending into new, high-growth markets
Extending into new, high-growth markets Extending into new markets Aim to diversify into close-adjacent markets where we have strong market understanding and brand awareness H1 FY2025 progress Launched a new position encoder line based on inductive encoder technology: • ASTRiA inductive encoders off
Slide 14: Outlook
Outlook Steady progress in H1 with demand picking up at the start of H2 • We have continued to make steady progress in mixed H2 range trading conditions. 2025 H2 2025 H1 Change £m £m % • Our order intake has recently improved, particularly from the Lower 354 +4% semiconductor manufacturing and consu
Slide 15: Disclaimer
Disclaimer This document contains statements about Renishaw plc that are or may be forward-looking statements. These forward-looking statements are not guarantees of future performance. They have not been reviewed by the auditors of Renishaw plc. They involve known and unknown risks, uncertainties a